Digestive Disease Week 2024Gastrointestinal diseasesdoi:10.1038/s41575-024-00954-9Katrina RayNature Publishing Group UKNature Reviews Gastroenterology & Hepatology
Korean Association for the Study of Intestinal Diseases Korean Society of Gastrointestinal Cancer Research 摘要征文投稿: Abstract Submission Deadline: August 28, 2024 点此提交摘要>>>Submit Abstract>>> Dear Colleagues and Friends, Welcome to the 2024 Korea Digestive Disease Week (KDDW 2024), proudly...
Cite this article Ray, K. Digestive Disease Week 2024. Nat Rev Gastroenterol Hepatol 21, 534 (2024). https://doi.org/10.1038/s41575-024-00954-9 Download citation Published17 June 2024 Issue DateAugust 2024 DOIhttps://doi.org/10.1038/s41575-024-00954-9 Subjects Gastrointestinal diseases Sectio...
Inflammatory diseases such as ulcerative colitis (UC), Crohn’s disease (CD), rheumatoid arthritis (RA), and multiple sclerosis (MS) have increased significantly since the onset of industrialization. The researchers investigated if there is a link between air pollution levels and the incidence of t...
Only here will you find your entire audience - eager to access groundbreaking findings, gain insight and inspiration and uncover solutions to improve the lives of those living with digestive diseases. Website: https://ddw.org/ Related Products: more products... Pioon Medical Laser M2Pioon ...
Digestive Disease Week® (DDW) will be held May 18-21, 2024, in Washington, DC. This annual event serves as the leading gathering for gastroenterologists, researchers, and industry professionals dedicated to improving outcomes for patients affected by gastrointestinal diseases. ...
Infectious diseases etc. are some of the products / services to be showcased in Digestive Disease Week. Helpful Puis-je obtenir une liste des intervenants participant à l’événement ? Puis-je obtenir une liste des exposants participant à l'événement ? Poser plus de questions ...
Digestive Disease Week (DDW 2026), May 2026, United States, organized by AGA Institute - American Gastroenterological Association. Find conference details | Conference Locate (Clocate)
Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced the results of its Phase 3 ZERO-1 study of JAQBO at Digestive Disease Week 2024, held in
(GI) diseases, yesterday presented two posters on celiac disease research at the 2024 Digestive Disease Week (DDW 2024) Conference in Washington, D.C. The presentations draw upon research from the robust clinical program investigating latiglutenase, an ...